Huadeng Tech BioArray Ventures Ltd - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Read More

Healthcare Industry News

111, Inc. founders propose $4.52-per-ADS buyout as Chinese healthcare platform weighs going private

111, Inc.'s co-founders and Huadeng Tech BioArray Ventures have proposed acquiring the remaining Nasdaq-listed healthcare platform shares for $4.52 per ADS in cash.

byPallavi Madhiraju

September 17, 2026

web analytics